Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azim M Mohamedali

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|July 23, 2013
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromesAustin G Kulasekararaj, Azim M Mohamedali, Ghulam J Mufti
Technology in Cancer Research & Treatment|June 5, 2003
IL-2 gene and antisense TGF-beta1 strategies counteract HSV-2 transformed tumor progressionJames D Kettering, Azim M Mohamedali, Lora M Green, et al.
Blood|June 14, 2013
Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndromeAzim M Mohamedali, Heba Alkhatabi, Austin Kulasekararaj, et al.
Haematologica|January 26, 2013
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignanciesTerry J Gaymes, Azim M Mohamedali, Miranda Patterson, et al.
Blood|August 21, 2014
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndromeAustin G Kulasekararaj, Jie Jiang, Alexander E Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|January 10, 2013
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndromeSyed A Mian, Alexander E Smith, Austin G Kulasekararaj, et al.
Nucleic Acids Research|February 11, 2012
A functional assay for microRNA target identification and validationJoop Gäken, Azim M Mohamedali, Jie Jiang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2012
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantationRachel H Westbrook, Nicholas C Lea, Azim M Mohamedali, et al.
British Journal of Haematology|January 10, 2013
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosisAustin G Kulasekararaj, Alexander E Smith, Syed A Mian, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|July 23, 2013
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromesAustin G Kulasekararaj, Azim M Mohamedali, Ghulam J Mufti
Technology in Cancer Research & Treatment|June 5, 2003
IL-2 gene and antisense TGF-beta1 strategies counteract HSV-2 transformed tumor progressionJames D Kettering, Azim M Mohamedali, Lora M Green, et al.
Blood|June 14, 2013
Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndromeAzim M Mohamedali, Heba Alkhatabi, Austin Kulasekararaj, et al.
Haematologica|January 26, 2013
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignanciesTerry J Gaymes, Azim M Mohamedali, Miranda Patterson, et al.
Blood|August 21, 2014
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndromeAustin G Kulasekararaj, Jie Jiang, Alexander E Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|January 10, 2013
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndromeSyed A Mian, Alexander E Smith, Austin G Kulasekararaj, et al.
Nucleic Acids Research|February 11, 2012
A functional assay for microRNA target identification and validationJoop Gäken, Azim M Mohamedali, Jie Jiang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2012
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantationRachel H Westbrook, Nicholas C Lea, Azim M Mohamedali, et al.
British Journal of Haematology|January 10, 2013
TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosisAustin G Kulasekararaj, Alexander E Smith, Syed A Mian, et al.
Pageof 2